FDA product code OWM: Prostate-Specific Antigen (Psa) For Prognostic, Recurrence Risk Assessment Of Prostate Cancers

OWM is the FDA product code for prostate-specific antigen (psa) for prognostic, recurrence risk assessment of prostate cancers. It is a Class II device, regulated under 21 CFR 866.6040 and reviewed by the Pathology panel. FDA has cleared 1 510(k) submission under OWM. The average 510(k) review took 510 days (median 510).

Definition

Determines rate of increase of total prostate specific antigen at ultrasensitive concentration levels (picogram/ml serum), and identifies those patients following prostatectomies which are at reduced risk for recurrence of prostate cancer.

Classification

FieldValue
Device nameProstate-Specific Antigen (Psa) For Prognostic, Recurrence Risk Assessment Of Prostate Cancers
Device classClass II
Regulation21 CFR 866.6040
Review panelPA — Pathology
Medical specialtyImmunology
Premarket route510(k)

Compare with all 510(k) review times · Search every OWM clearance

Top OWM applicants

ApplicantClearancesLatest
Iris Molecular Diagnostics12011-09-20

Most recent OWM clearances

510(k)ApplicantDeviceDecision dateReview days
K101185Iris Molecular DiagnosticsNUCLEIC ACID DETECTION IMMUNOASSAY (NADIA) PSA ASSAY2011-09-20510

Recalls for OWM devices

FDA recall records list no recalls for product code OWM.

Frequently asked questions

What is FDA product code OWM?

OWM is the FDA product code for prostate-specific antigen (psa) for prognostic, recurrence risk assessment of prostate cancers. It is a Class II device, regulated under 21 CFR 866.6040 and reviewed by the Pathology panel.

What device class is OWM?

Class II, regulation 21 CFR 866.6040. Typical premarket route: 510(k).

How long does a 510(k) take for product code OWM?

Across 1 cleared submissions the average was 510 days from receipt to decision (median 510).

Which companies have the most OWM clearances?

Iris Molecular Diagnostics (1).

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Pathology product codes · FDA product code lookup · 510(k) database search · 510(k) review times